Showing 1 - 3 results of 3 for search 'E. A. Kaledina', query time: 0.02s Refine Results
  1. 1
    Key differences between anti-PD-1/PD-L1 inhibitors

    Key differences between anti-PD-1/PD-L1 inhibitors by N. V. Zhukova, R. V. Orlova, E. A. Kaledina, P. A. Naymushina, A. M. Malkova, N. P. Beliak

    Published 2022-06-01
    Get full text
    Article
  2. 2
    Comparative analysis of IL-1β blood serum concentration, neutrophil-to-lymphocytes ratio in peripheral blood, and the levels of PD-L1 expression in malignant tissues of the patients with various solid tumors

    Comparative analysis of IL-1β blood serum concentration, neutrophil-to-lymphocytes ratio in peripheral blood, and the levels of PD-L1 expression in malignant tissues of the patient... by R. V. Orlova, N. V. Zhukova, A. M. Malkova, E. A. Kaledina, A. R. Gubal, V. V. Sharoiko

    Published 2021-11-01
    Get full text
    Article
  3. 3
    Limitations and opportunities of cancer treatment in the COVID-19 pandemic

    Limitations and opportunities of cancer treatment in the COVID-19 pandemic by R. V. Orlova, E. A. Kaledina, A. M. Malkova, N. V. Zhukova, P. A. Naymushina, N. P. Beliak, A. E. Jukova, A. S. Sarmatova, N. A. Karaseva, I. V. Egorova, K. N. Teslenko, A. V. Tarasov

    Published 2021-08-01
    Get full text
    Article

Search Tools: